3.91
Avalo Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
14.6
FY23:
0.64
FY24:
0.81
FY25:
0.06
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.1
FY22:
−37.4
FY23:
−27.4
FY24:
−68.5
FY25:
−72.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−80.5
FY22:
−37.3
FY23:
–
FY24:
−98.5
FY25:
−63.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.5
FY22:
−41.6
FY23:
−31.5
FY24:
−35.0
FY25:
−78.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−84.4
FY22:
−41.7
FY23:
−31.5
FY24:
−35.1
FY25:
−78.3
All amounts in millions USD